SurgiQuest said it won 510(k) clearance from the FDA for its AirSeal system, with indications for use in transanal endoscopic surgeries.AirSeal is designed to stably insufflate the rectum and provide continuous smoke evacuation, the Milford, Conn.-based company said. The system allows surgeons to perform transanal endoscopic surgeries more efficiently and confidently, according to the company.
“The AirSeal platform is a key factor in performing an ideal transanal total mesorectal excision procedure. By achieving a stable pneumorectum and providing optimal smoke evacuation, a meticulous dissection is possible,” Belgian colorectal surgeon Dr. Joep Knol said in a prepared statement.
SurgiQuest develops access technologies for minimally invasive surgery, including endoscopic and laparoscopic surgeries, the company said.
“The AirSeal system has had a significant impact on our ability to perform both transanal minimally invasive surgery and transanal total mesorectal excision procedures. From the first time I used it clinically, I knew this technology would elevate our surgical capabilities, improve patient outcomes, and help reduce procedure time and costs,” colorectal surgeon Dr. Matthew Albert of Orlando’s Florida Hospital said in a press release.
